{"name":"BrightGene Bio-Medical Technology Co., Ltd.","slug":"brightgene-bio-medical-technology-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"BGM0504 Administered SC","genericName":"BGM0504 Administered SC","slug":"bgm0504-administered-sc","indication":"Other","status":"phase_2"},{"name":"Drug: Placebo Administered SC","genericName":"Drug: Placebo Administered SC","slug":"drug-placebo-administered-sc","indication":"Other","status":"phase_3"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Drug: Semaglutide Administered SC","genericName":"Drug: Semaglutide Administered SC","slug":"drug-semaglutide-administered-sc","indication":"Type 2 diabetes mellitus","status":"phase_3"}]}],"pipeline":[{"name":"BGM0504 Administered SC","genericName":"BGM0504 Administered SC","slug":"bgm0504-administered-sc","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Drug: Placebo Administered SC","genericName":"Drug: Placebo Administered SC","slug":"drug-placebo-administered-sc","phase":"phase_3","mechanism":"Placebo has no active pharmacological mechanism; it is an inert substance used as a control in clinical trials.","indications":[],"catalyst":""},{"name":"Drug: Semaglutide Administered SC","genericName":"Drug: Semaglutide Administered SC","slug":"drug-semaglutide-administered-sc","phase":"phase_3","mechanism":"Semaglutide is a GLP-1 receptor agonist that mimics glucagon-like peptide-1 to regulate blood glucose, suppress appetite, and promote weight loss.","indications":["Type 2 diabetes mellitus","Chronic weight management in obese or overweight patients","Cardiovascular risk reduction in patients with type 2 diabetes"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNR0JhSmFUSUdJZ1ZOOHFJamJSdDdEU2hkakZOZWN4ZU9zRHp0NG85YU1oZUQ5LUNFelhpMmhJcVJLcHFUckh3T2FjalFwSTFYbTVNTXVLQTlXYUc3VUFQOTI3NGlzNUxlNnVxNE5vUjMxV2NvaTUyMlI4THRuTlpjbFZWS0dNcWZILU8zeXhySXI1MXVfaXR1b1ZjdW04bUtBWUR2M1l6ZFBVYnNFdHVVYVZMTThrLXBZLU9BMURyTQ?oc=5","date":"2026-03-25","type":"trial","source":"BioPharma APAC","summary":"BrightGene Reports Positive Phase 1 Results For Oral GLP 1 GIP Agonist BGM0504 - BioPharma APAC","headline":"BrightGene Reports Positive Phase 1 Results For Oral GLP 1 GIP Agonist BGM0504","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPQ0IyRmpWZzhoSnhlMVFEdVdtRzM2TjRtN0FfSXp5YjBSMHJVcGZwNlJxR09OODhWQWhIM3NRcV9pdEczQUhiaEs1aXpXYVlRWFlWb1k5QVVfd0t5bmQxRmVGblpDZVM4SmRtN2taaExmRU9KN3BmLU95bVRRM1V4aWtYaEZQVGpZNzRsOEVrSTdVc2FiVTFDcDJhb19DczA5M2IzM0FR?oc=5","date":"2025-12-09","type":"pipeline","source":"BioWorld News","summary":"73 Chinese biotech, med-tech companies file for HK IPOs in 2025 - BioWorld News","headline":"73 Chinese biotech, med-tech companies file for HK IPOs in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPT0VqZlBDclBYemlvd3hVTDRLOG5uS0pzMjgtM3plY0NvR3VyeXFzWlFOWmgyNGFWWXpuNjhxRFhUNmJhR2VjcGNkRjdWTlFjS19teG5NTnNZM3dQbklUb2dHU2JHYXBpdl9YOWthakgwQnZmU1V5Y09aZzVpUnNOR3RRbXlGMkxqZVc4SXhRZ1hlcmxu?oc=5","date":"2025-09-27","type":"pipeline","source":"富途牛牛","summary":"The “A+H” share boom continues! In September, a total of 20 A-share listed companies planned to list in Hong Kong, including PCB leaders such as沪电股份 (Greatek Electronics) and东山精密 (Dongshan Precision M","headline":"The “A+H” share boom continues! In September, a total of 20 A-share listed companies planned to list in Hong Kong, inclu","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBKZk40UnNFVmQ3ZEdEZUdoQVN1Q3BNSGw1MTl2N181ZDB4dlRGZ25hT1o1U2FvZ1RaWDEwbThibHFpQXRRdGNPcVZ5TlpPN04tWXI4?oc=5","date":"2024-12-01","type":"pipeline","source":"36 Kr","summary":"让一部分人先看到未来 - 36 Kr","headline":"让一部分人先看到未来 - 36 Kr","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPb3Y1WXM5R1hnWkdQdlRqSVN0M3JicE5mS0hOcHFSVm1zV09fQnEtWTVkZmFWU0FFYmUwa2g2Zm05cEVmd0owQTEyTk5COUpJeDNwV2NSWkQ3XzR6bE9GR0NHZERTbVduRlgwZmNZNXhVZDRCR2V4cC1BMVRXbTlZLXpkTFdtMTN2eVpzbVQ3NFBrQUd1VUZ4bjg1TkJTbExzVndZSHp0YmJJMVZaOHNB?oc=5","date":"2023-02-26","type":"pipeline","source":"Bloomberg.com","summary":"Flu Cases Surge in China, Leaving Antivirals in Short Supply - Bloomberg.com","headline":"Flu Cases Surge in China, Leaving Antivirals in Short Supply","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQMDR3YnpOYXprVUxjV3JtVXMtOEhxSWhaQnFhLUlPRGFfaTA1NnEyRDJFQnoxczNCNjRCd01sdVpqLXJ5V1lBaHhjNFJSd2ljT3JIdFltMDJVM3JqRnREaFFKeXVNMmR2UnBGamNsSFhsVHJJbjJxUUdHVjdCRklWemdoQTViY183TFV2YjVzTUdUamd6aWp5U3NHdGZOX2llODd3SW01MTFTd2VHOWE4UkZRUGktOHhlSzFxV0Vnb1c?oc=5","date":"2022-01-20","type":"deal","source":"WSJ","summary":"Fosun Pharma, Other Chinese Drugmakers Rise After Deal to Make Merck’s Covid-19 Pill - WSJ","headline":"Fosun Pharma, Other Chinese Drugmakers Rise After Deal to Make Merck’s Covid-19 Pill","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQalpKaXFGTzFOMlRCRnExYWp2LXVTM2tuS0QwdktSajktUzlmdzlGVWZBdzlsVmcyQjYtZ2hkbWo4WngyM2Ntekc2dFVNcDZyaXBYN2ZwaGFhRkhWSnRvTXVONENITlI4ak9DajZkbTEzOEZlVFBMRnZGbVdlZEh5QmU0NlNPYUk1V0xiM1NXaFgtQQ?oc=5","date":"2020-02-12","type":"pipeline","source":"pharmaphorum","summary":"J&J strengthens R&D into COVID-19 vaccine with US government - pharmaphorum","headline":"J&J strengthens R&D into COVID-19 vaccine with US government","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxOdmZlN2FoYjk2UlBZNG9JdW9uZENla095VUdGamZtQ0lNelVEOG55UnAtMERuME1GYjVRcFhkQ21Pc0ZobHczUXNVR0p3MldyZjhjSHB4ekJWUEpDX01keUh3N3dKUW9ILWhGTDN0OWhhNGhQZ0xyaHlSc05hbVBndWxFZDhMSktkR1Zla0kzZ3YzRnFtcHpYNXFUX1RoSDdSSmdmX2hJQmR1ckdnb3c?oc=5","date":"2016-02-10","type":"regulatory","source":"RAPS.org","summary":"US FDA Inspections in China: An Analysis of Form 483s from 2015 - RAPS.org","headline":"US FDA Inspections in China: An Analysis of Form 483s from 2015","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_2":1,"phase_3":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}